Relationship between Being Overweight and Clinical Outcomes of Ablation Therapy for Hepatocellular Carcinoma under Ultrasound Guidance: A Retrospective Analysis.
body mass index
hepatocellular carcinoma
microwave ablation
obesity paradox
overweight
radiofrequency ablation
technical success rate
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
17 Feb 2023
17 Feb 2023
Historique:
received:
02
02
2023
revised:
14
02
2023
accepted:
15
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
This study aimed to investigate the effect of being overweight on the outcome of ablation therapy for patients with early-stage hepatocellular carcinoma (HCC). This retrospective study included 198 patients with HCC who underwent radiofrequency ablation or microwave ablation at Gunma Saiseikai Maebashi Hospital between April 2017 and December 2021. We divided the patients into two groups based on their body mass index (BMI): overweight (BMI ≥ 25 kg/m
Identifiants
pubmed: 36831630
pii: cancers15041289
doi: 10.3390/cancers15041289
pmc: PMC9953948
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
N Engl J Med. 2008 Jul 24;359(4):378-90
pubmed: 18650514
J Gastroenterol Hepatol. 2011 Apr;26(4):759-64
pubmed: 21054516
Liver Int. 2016 Jun;36(6):817-26
pubmed: 26787002
PLoS One. 2015 May 12;10(5):e0125649
pubmed: 25965529
Prog Cardiovasc Dis. 2018 Jul - Aug;61(2):142-150
pubmed: 29981771
Lancet Gastroenterol Hepatol. 2016 Nov;1(3):196-206
pubmed: 28404092
J Hepatol. 2013 Jan;58(1):89-97
pubmed: 23023009
BMJ. 2021 Mar 16;372:n365
pubmed: 33727242
Am J Gastroenterol. 2012 Apr;107(4):569-77; quiz 578
pubmed: 22158026
Clin Gastroenterol Hepatol. 2007 Aug;5(8):938-45, 945.e1-4
pubmed: 17509946
Cancer Res. 2020 Jun 15;80(12):2564-2574
pubmed: 32213543
Int J Cancer. 2021 Apr 5;:
pubmed: 33818764
Prog Cardiovasc Dis. 2014 Jan-Feb;56(4):415-25
pubmed: 24438733
J Gastroenterol. 2011 Jan;46 Suppl 1:63-9
pubmed: 20844903
Curr Cardiol Rep. 2020 Mar 12;22(4):25
pubmed: 32166448
Lancet. 2018 Mar 24;391(10126):1163-1173
pubmed: 29433850
J Hepatol. 2018 Apr;68(4):783-797
pubmed: 29031662
BMJ. 2017 Feb 28;356:j477
pubmed: 28246088
J Hepatol. 2022 Mar;76(3):681-693
pubmed: 34801630
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Liver Cancer. 2021 Jun;10(3):181-223
pubmed: 34239808
N Engl J Med. 2020 May 14;382(20):1894-1905
pubmed: 32402160
Liver Cancer. 2021 Dec 29;11(3):209-218
pubmed: 35949295
J Hepatol. 2018 Jul;69(1):182-236
pubmed: 29628281
Liver Int. 2007 Apr;27(3):360-7
pubmed: 17355458
J Vasc Interv Radiol. 2014 Nov;25(11):1706-8
pubmed: 25442133
Hepatology. 2018 Jan;67(1):358-380
pubmed: 28130846
J Hepatol. 2012 Sep;57(3):508-14
pubmed: 22659518
Obes Surg. 2019 Mar;29(3):1031-1039
pubmed: 30591985
Aliment Pharmacol Ther. 2022 Aug;56(4):694-701
pubmed: 35707936
J Gastroenterol. 2019 Apr;54(4):367-376
pubmed: 30498904